SPXE.TO is trading at $9.06, up 6.34%, likely reflecting gains in SpaceX, its underlying asset, and a broader recovery after the recent technology selloff. - SpaceX was reported up more than 2% in premarket trading on November 9. - Stifel reiterated its Buy rating; a Starship test flight was planned as early as November 13, with an attempted dual-stage recovery. - Available evidence does not establish these catalysts’ precise contribution to SPXE.TO’s intraday move.